lamotrigine has been researched along with Eulenburg Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Stunnenberg, BC | 1 |
| LoRusso, S | 1 |
| Arnold, WD | 1 |
| Barohn, RJ | 1 |
| Cannon, SC | 1 |
| Fontaine, B | 2 |
| Griggs, RC | 1 |
| Hanna, MG | 1 |
| Matthews, E | 1 |
| Meola, G | 1 |
| Sansone, VA | 1 |
| Trivedi, JR | 1 |
| van Engelen, BGM | 1 |
| Vicart, S | 2 |
| Statland, JM | 1 |
| Desaphy, JF | 1 |
| Altamura, C | 1 |
| Andersen, G | 1 |
| Hedermann, G | 1 |
| Witting, N | 1 |
| Duno, M | 1 |
| Andersen, H | 1 |
| Vissing, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| High Intensity Interval Training in Patients With Facioscapulohumeral Muscular Dystrophy[NCT02159963] | 18 participants (Actual) | Interventional | 2014-06-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for lamotrigine and Eulenburg Disease
| Article | Year |
|---|---|
Guidelines on clinical presentation and management of nondystrophic myotonias.
Topics: Acetazolamide; Age of Onset; Carbonic Anhydrase Inhibitors; Chloride Channels; Electrodiagnosis; Ele | 2020 |
Targeted Therapies for Skeletal Muscle Ion Channelopathies: Systematic Review and Steps Towards Precision Medicine.
Topics: Channelopathies; Humans; Hypokalemic Periodic Paralysis; Lamotrigine; Mexiletine; Muscle, Skeletal; | 2021 |
1 trial available for lamotrigine and Eulenburg Disease
| Article | Year |
|---|---|
The antimyotonic effect of lamotrigine in non-dystrophic myotonias: a double-blind randomized study.
Topics: Adult; Aged; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Huma | 2017 |